Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Encision's free cash flow for the twelve months ending Sep 30, 2025 was -$544.87K, down 290.8% year over year. For fiscal 2025 it was -$109.36K, down 182.6% from the year before. The highest annual figure on record is $362.88K in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$109.36K | -182.6% |
| FY2024 | Mar 31, 2024 | $132.34K | – |
| FY2023 | Mar 31, 2023 | -$1.03M | – |
| FY2022 | Mar 31, 2022 | -$461.98K | -343.2% |
| FY2021 | Mar 31, 2021 | $189.93K | – |
| FY2020 | Mar 31, 2020 | -$277.81K | – |
| FY2019 | Mar 31, 2019 | -$182.49K | -150.3% |
| FY2018 | Mar 31, 2018 | $362.88K | – |
| FY2017 | Mar 31, 2017 | -$82.47K | – |
| FY2016 | Mar 31, 2016 | -$242.95K | – |
| FY2015 | Mar 31, 2015 | -$1.46M | – |
| FY2014 | Mar 31, 2014 | -$310.65K | – |
| FY2013 | Mar 31, 2013 | -$617.20K | – |
| FY2012 | Mar 31, 2012 | -$542.08K | – |
| FY2011 | Mar 31, 2011 | -$70.56K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$163.32K | -449.3% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$122.04K | -218.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$194.88K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$64.62K | -144.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $46.76K | +7.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $103.38K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$10.96K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $146.43K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $43.35K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$46.47K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$124.34K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$381.35K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$415.56K | -252.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$113.50K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$427.03K | -601.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$172.03K | -163.3% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $271.85K | +22977.2% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$134.77K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $85.08K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $271.86K | +83.5% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.18K | -98.2% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$164.41K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$179.95K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $148.13K | +128.0% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $65.99K | -67.0% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$311.97K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$299.82K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $64.97K | -31.7% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $199.69K | -24.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$147.33K | -259.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$89.88K | -516.5% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $95.06K | -20.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $265.49K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $92.21K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $21.58K | -64.2% |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $118.77K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$69.93K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$152.89K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $60.35K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$232.42K | – |
See a number that looks wrong?